Neutral impactCompany
AstraZeneca Pharma India Q1 profit drops to ₹37.93 crore
BusinessLine 1 hr ago·10 Aug 2026, 9:36 am
Revenue from operations in Q1 stood at ₹682.79 crore as against ₹526.31 crore in the same period a year ago
Affected stocks
Neutral1 stock
Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns AstraZeneca Pharma India (ASTRAZEN).
- Category: Company.
Why it matters
A routine update for AstraZeneca Pharma India. Use the price and stock snapshot to gauge how the market is responding.
